O’Melveny advised Evinced on the transaction. Evinced, the rapidly-growing technology leader in digital accessibility software, closed its US$55 million Series C funding round. The funding round...
Evinced’s $55 Million Series C Funding Round
EyecareLive’s Merger with Visibly
O’Melveny advised EyecareLive on the deal. EyecareLive, a digital vision care service that brings technology to eye doctors, patients, and pharmaceutical companies, announced its merger with...
Superfluid DX’s Oversubscribed Series A Financing
O’Melveny advised Superfluid DX on the transaction. Superfluid DX, a San Francisco-based company which specializes in advancing solutions for the diagnosis of Alzheimer’s disease, closed its...
Acquisition of GreenLight Biosciences by a Consortium Lead by Fall Line Endurance Fund for $45.5 Million
Goodwin Procter LLP is serving as legal counsel to the Company. Roth Capital Partners, LLC is serving as financial advisor and Foley Hoag LLP is serving...
GreenLight Biosciences Holdings’ Go-Private Transaction
Goodwin Procter advised GreenLight Biosciences, Foley Hoag advised the Special Committee, while O’Melveny & Myers advised Fall Line on the deal. GreenLight Biosciences Holdings, PBC (NASDAQ:...